Usher syndrome type 2 caused by activation of an USH2A pseudoexon: Implications for diagnosis and therapy

USH2A sequencing in three affected members of a large family, referred for the recessive USH2 syndrome, identified a single pathogenic alteration in one of them and a different mutation in the two affected nieces. As the patients carried a common USH2A haplotype, they likely shared a mutation not found by standard sequencing techniques. Analysis of RNA from nasal cells in one affected individual identified an additional pseudoexon (PE) resulting from a deep intronic mutation. This was confirmed by minigene assay. This is the first example in Usher syndrome (USH) with a mutation causing activation of a PE. The finding of this alteration in eight other individuals of mixed European origin emphasizes the importance of including RNA analysis in a comprehensive diagnostic service. Finally, this mutation, which would not have been found by whole‐exome sequencing, could offer, for the first time in USH, the possibility of therapeutic correction by antisense oligonucleotides (AONs). Hum Mutat 33:104–108, 2012. © 2011 Wiley Periodicals, Inc.

[1]  B. Gilbert-Dussardier,et al.  Four-year follow-up of diagnostic service in USH1 patients. , 2011, Investigative ophthalmology & visual science.

[2]  E. Stone,et al.  Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children , 2010, Genetics in Medicine.

[3]  M. Ugarte,et al.  Present and future of antisense therapy for splicing modulation in inherited metabolic disease , 2010, Journal of Inherited Metabolic Disease.

[4]  M. Claustres,et al.  Nasal epithelial cells are a reliable source to study splicing variants in Usher syndrome , 2010, Human mutation.

[5]  Monte Westerfield,et al.  PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. , 2010, The Journal of clinical investigation.

[6]  M. Claustres,et al.  Ex vivo splicing assays of mutations at noncanonical positions of splice sites in USHER genes , 2010, Human mutation.

[7]  E. Aller,et al.  The USH2A c.2299delG mutation: dating its common origin in a Southern European population , 2010, European Journal of Human Genetics.

[8]  E. Buratti,et al.  Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies , 2010, The FEBS journal.

[9]  G. Barratt,et al.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA , 2009, British journal of pharmacology.

[10]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[11]  A. Vielle,et al.  Molecular and in silico analyses of the full‐length isoform of usherin identify new pathogenic alleles in Usher type II patients , 2007, Human mutation.

[12]  E. Aller,et al.  Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II , 2006, Journal of Medical Genetics.

[13]  Ourania Horaitis,et al.  The challenge of documenting mutation across the genome: The human genome variation society approach , 2004, Human mutation.

[14]  C. Cremers,et al.  Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. , 2004, American journal of human genetics.

[15]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[16]  C. Cremers,et al.  A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. , 2001, American journal of human genetics.

[17]  T. Rosenberg,et al.  Identification of novel USH2A mutations: implications for the structure of USH2A protein , 2000, European Journal of Human Genetics.

[18]  K. Steel,et al.  A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. , 1999, American journal of human genetics.

[19]  C. Möller,et al.  Clinical diagnosis of the Usher syndromes , 1994 .

[20]  C. Möller,et al.  Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. , 1994, American journal of medical genetics.